Clinical Study of Safety and Efficacy of a Polymer-Subunit Adjuvant Influenza Vaccine Applied in Combination with an Immune Modulator in People Aged 60 and Over
Relevance. In Russia, acute respiratory viral infections (ARVI) account for 93% of all infectious diseases. Flu is more serious disease than many ARVI. Flu especially dangerous for people aged 60 years or older, for the reason that they have a weakened immune system, and as a rule there are a chroni...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2016-10-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/364 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|